BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30387070)

  • 1. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
    Rowland HA; Hooper NM; Kellett KAB
    Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
    Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
    Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples.
    Verheijen MCT; Krauskopf J; Caiment F; Nazaruk M; Wen QF; van Herwijnen MHM; Hauser DA; Gajjar M; Verfaillie C; Vermeiren Y; De Deyn PP; Wittens MMJ; Sieben A; Engelborghs S; Dejonckheere W; Princen K; Griffioen G; Roggen EL; Briedé JJ
    Toxicol Lett; 2022 Mar; 356():89-99. PubMed ID: 34921933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
    Sahlgren Bendtsen KM; Hall VJ
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
    Riemens RJM; Kenis G; van den Beucken T
    Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
    Foveau B; Correia AS; Hébert SS; Rainone S; Potvin O; Kergoat MJ; Belleville S; Duchesne S; LeBlanc AC;
    J Alzheimers Dis; 2019; 67(3):893-910. PubMed ID: 30689579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
    Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
    Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
    Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
    Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling amyloid beta and tau pathology in human cerebral organoids.
    Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
    Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease in a dish: promises and challenges of human stem cell models.
    Young JE; Goldstein LS
    Hum Mol Genet; 2012 Oct; 21(R1):R82-9. PubMed ID: 22865875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
    Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
    Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
    Culibrk RA; Ebbert KA; Yeisley DJ; Chen R; Qureshi FA; Hahn J; Hahn MS
    J Alzheimers Dis; 2024; 98(1):301-318. PubMed ID: 38427475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.
    Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; Cam HP; Gjoneska E; Raja WK; Cheng J; Rueda R; Kritskiy O; Abdurrob F; Peng Z; Milo B; Yu CJ; Elmsaouri S; Dey D; Ko T; Yankner BA; Tsai LH
    Neuron; 2018 Jun; 98(6):1141-1154.e7. PubMed ID: 29861287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.
    van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB
    Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.